Clinical Scorecard: Keratoconus in Hormonal Flux
At a Glance
| Category | Detail |
|---|---|
| Condition | Keratoconus (KCN) |
| Key Mechanisms | Hormonal fluctuations, particularly involving the hypothalamic–pituitary–gonadal (HPG) axis hormones. |
| Target Population | Adults from early twenties to late fifties, particularly during significant hormonal changes. |
| Care Setting | Ophthalmology clinics and practices. |
Key Highlights
- Hormonal fluctuations, especially during pregnancy, are linked to KCN onset and progression.
- Elevated DHEAS levels consistently reported in KCN patients.
- Systematic review included 26 studies with over 4,200 participants.
- Integration of hormonal history into KCN risk assessment is recommended.
- Proposed targeted screening pathways for vulnerable groups.
Guideline-Based Recommendations
Diagnosis
- Consider hormonal history in KCN risk assessment.
Management
- Monitor hormonal levels during significant hormonal changes.
Monitoring & Follow-up
- Be alert to periods of hormonal fluctuation as potential windows of vulnerability.
Risks
- Increased risk of KCN onset or progression linked to hormonal shifts.
Patient & Prescribing Data
Adults experiencing hormonal changes, including pregnancy and those on hormone therapy.
Hormonal therapies may influence KCN progression; careful monitoring is advised.
Clinical Best Practices
- Implement proactive screening for KCN in patients with known hormonal fluctuations.
- Educate patients on the potential impact of hormonal changes on KCN.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
